Follow-up Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-L)

Clinical trial NCT07023965 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT07023965
Sponsor: Beijing Northland Biotech. Co., Ltd.
Status: ENROLLING_BY_INVITATION
Study type: OBSERVATIONAL

Peripheral Arterial Disease(PAD)Arterial Occlusive Disease Arteriosclerosis Obliterans Thromboangiitis Obliterans Diabetic Foot Ulcer (DFU)Diabetic Foot Ulcer Ischemic Critical Limb Ischemia (CLI)

Start date: 2025-06-30
Primary completion: 2027-12-31
Enrollment: 542

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.